Live feed07:08:20·1218dSECFilingvia QuantisnowAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.ADMP· Adamis Pharmaceuticals CorporationHealth CareOriginal source
